Details for 2017160683

Up to date per 02.04.2026

Actions

Title / Product Name

9-(1H-IMIDAZOL-5-YL)-1,11-DIHYDROISOCHROMENO[4',3':6,7]NAPHTHO[1,2-D]IMIDAZOL- DERIVATE UND IHRE VERWENDUNG ALS HCV NS5A INHIBITOREN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017160683

EP Publication Number

3239153

E-Number

1129980

Language

PCT Number

Publication Date

01.11.2017 A

08.05.2019 B1

Registration Date

08.05.2019

AT Publication Date

15.05.2019

Application Date

15.05.2013

Registration Number

Priorities

16.05.2012

201261647966 P

14.03.2013

201313831116

IPC

C07D 491/052 20060101AFI20181026BHEP

Maximum Duration of Protection

15.05.2033

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, California 94404US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

BACON, Elizabeth M.c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404US

COTTELL, Jeromy J.c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404US

LINK, John O.c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404US

TREJO MARTIN, Teresa Alejandrac/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA California 94404US

Information about Fees